Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Femoral stenting: what do the guidelines tell us.

Minar E.

J Cardiovasc Surg (Torino). 2013 Apr;54(2):211-5. Review.

PMID:
23558656
2.

Failed superficial femoral artery intervention for advanced infrainguinal occlusive disease has a significant negative impact on limb salvage.

Al-Nouri O, Krezalek M, Hershberger R, Halandras P, Gassman A, Aulivola B, Milner R.

J Vasc Surg. 2012 Jul;56(1):106-10; discussion 110-1. doi: 10.1016/j.jvs.2011.10.108. Epub 2012 Jan 5.

3.

Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.

Allemang MT, Rajani RR, Nelson PR, Hingorani A, Kashyap VS.

Ann Vasc Surg. 2013 Jan;27(1):62-7. doi: 10.1016/j.avsg.2012.05.001. Epub 2012 Sep 12.

PMID:
22981017
4.

Chapter IV: Treatment of critical limb ischaemia.

Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, Robert-Ebadi H, Cao P, Eckstein HH, De Rango P, Diehm N, Schmidli J, Dick F, Davies AH, Lepäntalo M, Apelqvist J.

Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S43-59. doi: 10.1016/S1078-5884(11)60014-2. Review.

5.

Intravascular brachytherapy for peripheral vascular disease.

Andras A, Hansrani M, Stewart M, Stansby G.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD003504. doi: 10.1002/14651858.CD003504.pub2. Review.

PMID:
24399686
6.

Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies: Transatlantic Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC).

Ricco JB, Parvin S, Veller M, Brunkwall J, Wolfe J, Sillesen H, Eckstein HH, Fitridge R.

Eur J Vasc Endovasc Surg. 2014 Feb;47(2):118. doi: 10.1016/j.ejvs.2013.11.009. Epub 2013 Nov 28. No abstract available.

7.

TASC II and the endovascular management of infrainguinal disease.

Lyden SP, Smouse HB.

J Endovasc Ther. 2009 Apr;16(2 Suppl 2):II5-18. doi: 10.1583/08-2659.1. Review.

PMID:
19624072
8.

Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.

Katsanos K, Tepe G, Tsetis D, Fanelli F.

Cardiovasc Intervent Radiol. 2014 Jun;37(3):592-603. doi: 10.1007/s00270-014-0876-3. Epub 2014 Apr 11.

PMID:
24722891
9.

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

TASC Steering Committee, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L.

J Endovasc Ther. 2015 Oct;22(5):663-77. doi: 10.1177/1526602815592206. Epub 2015 Aug 3. Review.

PMID:
26239796
10.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease.

Malas MB, Enwerem N, Qazi U, Brown B, Schneider EB, Reifsnyder T, Freischlag JA, Perler BA.

J Vasc Surg. 2014 Jan;59(1):129-35. doi: 10.1016/j.jvs.2013.05.100. Epub 2013 Jul 24.

11.

Peripheral arterial disease: an overview of endovascular therapies and contemporary treatment strategies.

Singh KP, Patel MR, Kandzari DE, Zidar JP.

Rev Cardiovasc Med. 2006 Spring;7(2):55-68. Review.

PMID:
16915124
12.

Transradial approach as first choice for stenting of chronic total occlusion of iliac and femoral superficial artery.

Antov S, Kedev S.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(3):13-24.

PMID:
24566011
13.

Antiplatelet therapy in peripheral arterial disease. Consensus statement.

Peripheral Arterial Diseases Antiplatelet Consensus Group.

Eur J Vasc Endovasc Surg. 2003 Jul;26(1):1-16. Review.

14.

Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines.

Mohler E 3rd, Giri J; ACC; AHA.

Curr Med Res Opin. 2008 Sep;24(9):2509-22. doi: 10.1185/03007990802274379 . Epub 2008 Jul 28. Review.

PMID:
18664318
15.

Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.

Schneider JR, Verta MJ, Alonzo MJ, Hahn D, Patel NH, Kim S.

Vasc Endovascular Surg. 2011 Jul;45(5):391-7. doi: 10.1177/1538574411405548. Epub 2011 Jun 12.

PMID:
21669863
16.

TASC II document on the management of peripheral arterial disease.

Adam DJ, Bradbury AW.

Eur J Vasc Endovasc Surg. 2007 Jan;33(1):1-2. No abstract available.

17.

[The outcome of femoropopliteal bypass].

Narita H, Komori K.

Nihon Geka Gakkai Zasshi. 2010 Mar;111(2):88-90. Japanese.

PMID:
20387587
18.

Molecular mechanisms of restenosis after percutaneous peripheral angioplasty and approach to endovascular therapy.

Mongiardo A, Curcio A, Spaccarotella C, Parise S, Indolfi C.

Curr Drug Targets Cardiovasc Haematol Disord. 2004 Sep;4(3):275-87. Review.

PMID:
15379621
19.

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

TASC Steering Committee, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, Reekers J, Norgren L.

Vasc Med. 2015 Oct;20(5):465-78. doi: 10.1177/1358863X15597877. Epub 2015 Aug 12. Review.

PMID:
26268268
20.

Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss.

Lantis J, Jensen M, Benvenisty A, Mendes D, Gendics C, Todd G.

Ann Vasc Surg. 2008 May-Jun;22(3):366-71. doi: 10.1016/j.avsg.2007.09.016.

PMID:
18466815

Supplemental Content

Support Center